David Tepper and 33 Other Funds Bought Software Stocks. CoreWeave Is Down 43% Since. Time to Buy?
CoreWeave's stock has fallen 43% since August, with analysts cutting targets. NVIDIA's CEO resignation and yield concerns add risk. Oracle and Core Scientific face similar challenges. ServiceNow and Akamai reported mixed results. CoreWeave's next loan yield and NVIDIA's report are key to watch.
How this was made
The 30-second read
Why it matters
CoreWeave’s expected next loan yield and dependency on NVIDIA capacity support are the key near-term risk drivers. ServiceNow and Akamai provide counterpoints via guidance and margin signals, while Oracle and Core Scientific are discussed through backlog and contractual exposure to the same AI build-out.
Market read
Traders can use the article’s specific financing-yield expectation for CoreWeave and the guidance/margin datapoints for ServiceNow and Akamai to reassess near-term risk and valuation assumptions.
What to watch
The article emphasizes analyst targets and financing yields but does not quantify CoreWeave’s liquidity runway or contract renegotiation terms; for Oracle and NVIDIA, the linkage is described rather than evidenced by a new contract change.
Background
The piece frames a post-IPO AI infrastructure drawdown for CoreWeave, with analyst target cuts and financing-cost repricing, while contrasting with software and networking peers’ own guidance and margin developments.
Ticker impact
CoreWeave’s next contract-backed loan is expected to price at a 7% to 7.5% yield, raising dilution and lender-share risk as chips support is uncertain.
Likely downside or continued volatility as the market prices higher cost of capital and uncertain capacity support.
The article ties CoreWeave’s funding economics directly to a new loan yield expectation and highlights a key dependency on NVIDIA’s post-resignation leadership decisions.
ServiceNow guided fourth-quarter cRPO growth to 18.5% versus ~19.8% expected, while raising its AI annual contract value target to $1.7 billion.
Likely modest pressure or choppy trading as investors weigh the cRPO miss against AI ACV strength.
The article provides both a specific guidance shortfall and an offsetting AI ACV increase, implying competing signals for near-term valuation.
Akamai reported Q3 revenue growth to $1.12 billion, saw non-GAAP operating margin fall to 25%, and cut full-year revenue guidance.
Likely downside bias as the market reprices full-year revenue and margin trajectory.
The article explicitly states a full-year revenue guidance cut and margin decline, which typically dominate over discretionary insider buying.
Oracle is described as having OpenAI as about half its backlog, with OpenAI’s latest funding round reaching $15 billion, while Oracle’s average target has fallen sharply.
Likely range-bound to slightly negative as investors focus on the lowered analyst targets despite the OpenAI backlog linkage.
The piece links Oracle to OpenAI backlog and funding, but it does not present a fresh Oracle-specific operational disclosure beyond analyst-target movement.
Core Scientific leases about 590 megawatts to CoreWeave under 12-year contracts worth $10.2 billion, while its total debt has roughly quadrupled since December.
Likely negative bias as debt growth and exposure to CoreWeave economics raise perceived risk.
The article provides a concrete debt deterioration and a direct contractual linkage to CoreWeave capacity.
Jensen Huang resigned as NVIDIA’s CEO, and the article notes NVIDIA supplies CoreWeave’s chips and rents back its capacity.
Likely limited direct impact on NVDA unless investors infer changes to supply or capacity economics; could add volatility around the dependency narrative.
The article’s NVDA details are largely contextual to CoreWeave’s risk, not a new NVDA-specific policy or contract change.
Market effects
Reinforces that AI infrastructure financing costs and customer concentration risk are central to valuation, pressuring highly levered operators while rewarding cash-generative software.
Primarily US-listed growth and software complex; sentiment spillover into AI infrastructure and enterprise SaaS.
Highlights global AI supply-chain dependencies (chip supply and capacity leasing) that can affect cross-border AI capex narratives.
Counterpoint
CoreWeave’s higher loan yield could be a one-time repricing, and ServiceNow’s AI ACV target raise may outweigh the cRPO guide softness, supporting selective dip-buying.
Key entities
- companyCoreWeave
AI infrastructure provider facing higher expected contract-backed loan yields and uncertainty around NVIDIA support.
- companyServiceNow
Enterprise software firm with slightly light cRPO guidance but raised AI annual contract value target.
- companyAkamai
Networking/CDN company that cut full-year revenue guidance after margin compression.
- companyOracle
Enterprise software firm with OpenAI-linked backlog exposure and sharply lower analyst targets.
- companyCore Scientific
Leased-power counterparty to CoreWeave with rapidly rising debt.


